Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
81.56
+1.56 (1.95%)
Aug 6, 2026, 9:50 AM EDT - Market open
Bright Minds Biosciences Employees
Bright Minds Biosciences had 26 employees as of September 30, 2025. The number of employees increased by 25 or 2,500.00% compared to the previous year.
Employees
26
Change (1Y)
25
Growth (1Y)
2,500.00%
Revenue / Employee
n/a
Profits / Employee
-$753,699
Market Cap
766.86M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 26 | 25 | 2,500.00% |
| Sep 30, 2024 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pharming Group | 407 |
| Phathom Pharmaceuticals | 371 |
| Rigel Pharmaceuticals | 174 |
| Aura Biosciences | 113 |
| Aclaris Therapeutics | 73 |
| CytomX Therapeutics | 69 |
| SpyGlass Pharma | 68 |
| Oculis Holding AG | 60 |
DRUG News
- 6 days ago - Vistagen Appoints Douglas J. Williamson to its Board of Directors - GlobeNewsWire
- 4 weeks ago - New Options Listings: Bright Minds Biosciences (DRUG) - GuruFocus
- 2 months ago - Bright Minds Biosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline - The Motley Fool
- 2 months ago - Bright Minds price target raised to $220 from $190 at Piper Sandler - TheFly
- 2 months ago - Bright Minds Biosciences Registration statement: Q2 2026 - Filings
- 2 months ago - Bright Minds Biosciences Registration statement: Q2 2026 - Filings